在先天性高胰岛素症中的二氧化毒性:一个病例报告
Roberta Pajno1, Camilla Visconti2,3, Carmen Bucolo2
1Department of Pediatrics, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Institute, Milan 20132, Lombardy, Italy. pajno.roberta@hsr.it.
World journal of clinical pediatrics
|December 10, 2024
概括
用于先天性高胰岛素症的氧化物可以引起罕见的心脏副作用,如心周溢出. 及时识别和管理,包括药物戒断和利尿剂使用,对于患者的安全至关重要.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 氧化物是先天性高胰岛素症 (CHI) 的首要治疗方法.
- 由于潜在的危及生命的并发症,对不良影响的监测至关重要.
- 本报告侧重于一种罕见的,未被认可的氧化物治疗的副作用.
研究的目的:
- 在患有先天性高胰岛素症的患者中报告二氧化的罕见心脏副作用.
- 强调对氧化物诱导的不良事件的警监测和及时干预的重要性.
- 提高医生对潜在的二氧化并发症的认识.
主要方法:
- 一个患者的病例报告CHI用diazoxide治疗.
- 详细的临床表现包括突发呼吸困难和心脏发现 (心周溢血,左心室缩).
- 诊断工作包括心声回声,PET/CT和外科病理学;治疗调整涉及减氧化和利尿剂的启动.
主要成果:
- 患者在开始服用氧化物后出现心周溢血和左心室肌肉缩.
- 停用氧化物和引入利尿剂导致症状消失.
- 诊断成像证实了焦点形式的高胰岛素症,成功地通过远端胰腺切除术治疗.
结论:
- 在二氧化治疗期间进行警监测对于识别严重不良反应至关重要.
- 及时识别和管理,包括药物停用和支持性护理 (例如利尿剂) 是至关重要的.
- 这一案例凸显了考虑罕见副作用和遵守治疗指南的重要性.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Pathophysiology of Diabetes
866
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
866
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Insulin: Dosing Regimen and Adverse Effects
145
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
145
Hypoglycemia and Glucagon
152
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
152
Heart Failure Drugs: Inotropic Agents
517
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
517


